Literature DB >> 21148796

Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation.

Ryan H Newton1, Sabrina Leverrier, Sonal Srikanth, Yousang Gwack, Michael D Cahalan, Craig M Walsh.   

Abstract

DRAK2 is a serine/threonine kinase highly enriched in lymphocytes that raises the threshold for T cell activation and maintains T cell survival following productive activation. T cells lacking DRAK2 are prone to activation under suboptimal conditions and exhibit enhanced calcium responses to AgR stimulation. Despite this, mice lacking DRAK2 are resistant to organ-specific autoimmune diseases due to defective autoreactive T cell survival. DRAK2 kinase activity is induced by AgR signaling, and in this study we show that the induction of DRAK2 activity requires Ca(2+) influx through the Ca(2+) release-activated Ca(2+) channel formed from Orai1 subunits. Blockade of DRAK2 activity with the protein kinase D (PKD) inhibitor Gö6976 or expression of a kinase-dead PKD mutant prevented activation of DRAK2, whereas a constitutively active PKD mutant promoted DRAK2 function. Knockdown of PKD in T cells strongly blocked endogenous DRAK2 activation following TCR ligation, implicating PKD as an essential intermediate in the activation of DRAK2 by Ca(2+) influx. Furthermore, we identify DRAK2 as a novel substrate of PKD, and demonstrate that DRAK2 and PKD physically interact under conditions that activate PKD. Mitochondrial generation of reactive oxygen intermediates was necessary and sufficient for DRAK2 activation in response to Ca(2+) influx. Taken together, DRAK2 and PKD form a novel signaling module that controls calcium homeostasis following T cell activation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148796      PMCID: PMC3133617          DOI: 10.4049/jimmunol.1000942

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Oxidative stress induces protein kinase D activation in intact cells. Involvement of Src and dependence on protein kinase C.

Authors:  R T Waldron; E Rozengurt
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 2.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 3.  Protein kinase Ctheta: a new essential superstar on the T-cell stage.

Authors:  A Altman; N Isakov; G Baier
Journal:  Immunol Today       Date:  2000-11

Review 4.  The DAP kinase family of pro-apoptotic proteins: novel players in the apoptotic game.

Authors:  D Kögel; J H Prehn; K H Scheidtmann
Journal:  Bioessays       Date:  2001-04       Impact factor: 4.345

5.  Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria.

Authors:  César Cárdenas; Russell A Miller; Ian Smith; Thi Bui; Jordi Molgó; Marioly Müller; Horia Vais; King-Ho Cheung; Jun Yang; Ian Parker; Craig B Thompson; Morris J Birnbaum; Kenneth R Hallows; J Kevin Foskett
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

6.  Inhibition of PTPs by H(2)O(2) regulates the activation of distinct MAPK pathways.

Authors:  Kyoungmun Lee; Walter J Esselman
Journal:  Free Radic Biol Med       Date:  2002-10-15       Impact factor: 7.376

7.  RasGRP is essential for mouse thymocyte differentiation and TCR signaling.

Authors:  N A Dower; S L Stang; D A Bottorff; J O Ebinu; P Dickie; H L Ostergaard; J C Stone
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

8.  Glutamine protects activated human T cells from apoptosis by up-regulating glutathione and Bcl-2 levels.

Authors:  Wei-Kuo Chang; Kuender D Yang; Hau Chuang; Jia-Tsong Jan; Men-Fang Shaio
Journal:  Clin Immunol       Date:  2002-08       Impact factor: 3.969

Review 9.  Hydrogen peroxide as second messenger in lymphocyte activation.

Authors:  Michael Reth
Journal:  Nat Immunol       Date:  2002-12       Impact factor: 25.606

10.  Protein kinase D. A selective target for antigen receptors and a downstream target for protein kinase C in lymphocytes.

Authors:  S A Matthews; E Rozengurt; D Cantrell
Journal:  J Exp Med       Date:  2000-06-19       Impact factor: 14.307

View more
  7 in total

1.  Serine/threonine kinase 17b (STK17B) signalling regulates Purkinje cell dendritic development and is altered in multiple spinocerebellar ataxias.

Authors:  Qin-Wei Wu; Josef P Kapfhammer
Journal:  Eur J Neurosci       Date:  2021-09-29       Impact factor: 3.698

2.  Orai1 function is essential for T cell homing to lymph nodes.

Authors:  Milton L Greenberg; Ying Yu; Sabrina Leverrier; Shenyuan L Zhang; Ian Parker; Michael D Cahalan
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

Review 3.  Signaling pathways in aged T cells - a reflection of T cell differentiation, cell senescence and host environment.

Authors:  Jörg J Goronzy; Guangjin Li; Mingcan Yu; Cornelia M Weyand
Journal:  Semin Immunol       Date:  2012-05-04       Impact factor: 11.130

4.  Drak2 Does Not Regulate TGF-β Signaling in T Cells.

Authors:  Tarsha L Harris; Maureen A McGargill
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

Review 5.  Computational properties of mitochondria in T cell activation and fate.

Authors:  Roman Uzhachenko; Anil Shanker; Geneviève Dupont
Journal:  Open Biol       Date:  2016-11       Impact factor: 6.411

Review 6.  Modulation of T Cell Metabolism and Function through Calcium Signaling.

Authors:  Kelley M Fracchia; Christine Y Pai; Craig M Walsh
Journal:  Front Immunol       Date:  2013-10-11       Impact factor: 7.561

7.  DAP Kinase-Related Apoptosis-Inducing Protein Kinase 2 (DRAK2) Is a Key Regulator and Molecular Marker in Chronic Lymphocytic Leukemia.

Authors:  Katarzyna Szoltysek; Carmela Ciardullo; Peixun Zhou; Anna Walaszczyk; Elaine Willmore; Vikki Rand; Scott Marshall; Andy Hall; Christine J Harrison; Jeyanthy Eswaran; Meera Soundararajan
Journal:  Int J Mol Sci       Date:  2020-10-16       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.